Mobia Medical (NASDAQ:MOBI) Releases Earnings Results

Mobia Medical (NASDAQ:MOBI) announced its quarterly earnings data on Thursday. The company reported $999.00 EPS for the quarter, Zacks reports.

Mobia Medical Stock Performance

NASDAQ:MOBI traded up $0.11 during mid-day trading on Thursday, reaching $13.84. The stock had a trading volume of 240,618 shares, compared to its average volume of 173,512. Mobia Medical has a fifty-two week low of $10.19 and a fifty-two week high of $14.77. The company has a market capitalization of $457.90 million, a P/E ratio of 66.00 and a beta of 2.84.

Insiders Place Their Bets

In related news, Director Dana G. Jr. Mead acquired 7,000 shares of the business’s stock in a transaction on Monday, May 11th. The stock was bought at an average cost of $15.00 per share, with a total value of $105,000.00. Following the completion of the acquisition, the director owned 7,000 shares in the company, valued at $105,000. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Chase C. Leavitt acquired 3,000 shares of the business’s stock in a transaction on Monday, May 11th. The shares were bought at an average cost of $15.00 per share, with a total value of $45,000.00. Following the completion of the acquisition, the insider owned 3,000 shares of the company’s stock, valued at approximately $45,000. This trade represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. Insiders have acquired a total of 1,268,332 shares of company stock valued at $19,024,980 in the last 90 days.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Wall Street Zen upgraded shares of Mobia Medical to a “hold” rating in a research note on Saturday, May 16th. BTIG Research initiated coverage on shares of Mobia Medical in a report on Tuesday. They issued a “buy” rating and a $19.00 target price for the company. The Goldman Sachs Group initiated coverage on shares of Mobia Medical in a research report on Tuesday. They set a “buy” rating and a $31.00 price target on the stock. Bank of America assumed coverage on shares of Mobia Medical in a report on Tuesday. They issued a “buy” rating and a $16.00 price target on the stock. Finally, JPMorgan Chase & Co. began coverage on shares of Mobia Medical in a report on Tuesday. They set an “overweight” rating and a $15.00 target price on the stock. Five research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $20.25.